Semaglutide Injectable Suppliers & Bulk Manufacturers
Available Forms: Injection(SQ)
Available Strengths: 0,25 mg - 2.4 mg per injection for weight management
Reference Brands: Wegovy(US & EU)
Category: Weight Loss drugs
Wegovy (semaglutide 2.4 mg) is a GLP-1 receptor agonist that mimics natural hormones to increase insulin secretion, suppress appetite, and slow gastric emptying. It supports weight loss, improves metabolic health, reduces hunger, and helps manage obesity, promoting long-term weight reduction and overall wellness. Semaglutide Injectable is available in Injection(SQ) and strengths such as 0,25 mg - 2.4 mg per injection for weight management. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Semaglutide Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Semaglutide Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Wegovy (semaglutide 2.4 mg) injection is approved in the US by the FDA and in the EU via EMA for chronic weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe administration, and global availability, helping patients worldwide achieve significant weight loss and improved metabolic health through high-quality, long-acting GLP-1 receptor agonist therapies.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Semaglutide is used to improve blood sugar control in adults with type 2 diabetes mellitus and to aid in chronic weight management for obese or overweight individuals with related health conditions. It helps lower blood glucose levels by stimulating insulin release and reducing appetite.
Semaglutide is a synthetic peptide analogue of human glucagon-like peptide-1 (GLP-1). It is produced through recombinant DNA technology in yeast and modified to resist enzymatic degradation, allowing longer activity in the body.
The main trade names of Semaglutide are Ozempic, Wegovy, and Rybelsus.
Semaglutide is manufactured by Novo Nordisk A/S.
The generic name is Semaglutide.
Brand names include Ozempic (for type 2 diabetes), Wegovy (for weight management), and Rybelsus (oral form for diabetes).
Semaglutide is manufactured by Novo Nordisk in Denmark and also at its production facilities in the United States.
Related Products
Phentermine Hydrochloride
Strength:
8 mg, 15 mg, 30 mg, 37.5 mg
Form: Tablets, Capsules
Reference Brands: Adipex-P (USA), Ionamin (USA)
View Details
Diethylpropion Hydrochloride
Strength:
25mg, 75mg
Form: Tablets
Reference Brands: Tenuate (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
